AXONIS THERAPEUTICS, INC.

formerly Axonis

Reviving Neurons - Restoring Control

Boston, United States · Founded 2020 · $127.5M raised

Employees
11–50
Founded
2020
Business Model
B2B
Website
axonis.us
Total Funding
$127.5M
Last Round
$115.0M Series AOct 2024
Rounds
8

About

Axonis Therapeutics is a Boston-based, neuro-focused biotechnology company developing first- and best-in-class medicines targeting KCC2, a critical mediator of inhibition within the brain. The company translates breakthrough discoveries spun out from Boston Children's Hospital, Harvard, and Laval University into oral therapeutics for currently incurable neurological disorders including pain, epilepsy, and psychiatric conditions. Axonis raised $115M in a Series A round in October 2024 to fund Phase I clinical trials.

Summary

AXONIS THERAPEUTICS, INC. is a Biotech company based in Boston, United States, founded in 2020. It has raised $127.5M in total across 8 rounds, most recently a $115.0M Series A round in Oct 2024. Investors include Cormorant Asset Management, venBIO Partners and Sofinnova Investments.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AOct 2024
$115.0M

Sign up to see all 8 rounds

Seed through Series A — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

AXONIS THERAPEUTICS, INC. on Indexed.vc
<a href="https://indexed.vc/companies/axonis-therapeutics-inc"><img src="https://indexed.vc/api/badge/company/axonis-therapeutics-inc" alt="AXONIS THERAPEUTICS, INC. on Indexed.vc" width="260" height="76" /></a>